title: Renal amyloidosis and angioimmunoblastic lymphadenopathy.
authors.affiliation: Department of Nephrology, Queen Elizabeth Hospital, Birmingham, UK.
authors.forename: A K
authors.initials: AK
authors.lastname: Lim
authors.forename: M A
authors.initials: MA
authors.lastname: Ferreira
authors.forename: A
authors.initials: A
authors.lastname: Majumdar
authors.forename: D C
authors.initials: DC
authors.lastname: Wheeler
authors.forename: G W
authors.initials: GW
authors.lastname: Lipkin
mesh_terms: D000328:Adult; D000686:Amyloidosis / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003520:Cyclophosphamide / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage; D006801:Humans; D007119:Immunoblastic Lymphadenopathy / Q000150:complications* / Q000473:pathology; D007674:Kidney Diseases / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D008297:Male; D011239:Prednisolone / Q000008:administration & dosage; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011239:Prednisolone